Assignee
ONCORAL PHARMA APS
DK·3 granted patents·3 citations·filing 2015–2022
Top patents by PatentIndex Score
3 records- 0178US10143657B2Solid oral dosage form of irinotecan for the treatment of cancerONCORAL PHARMA APS·Filed 2015·Granted Dec 4, 2018·3 cites·19 claims
- 0267US11666537B2Solid oral dosage form of irinotecan for the treatment of cancerONCORAL PHARMA APS·Filed 2022·Granted Jun 6, 2023·0 cites·21 claims
- 0355US11419825B2Solid oral dosage form of irinotecan for the treatment of cancerONCORAL PHARMA APS·Filed 2018·Granted Aug 23, 2022·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when ONCORAL PHARMA APS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →